Role of hypofractionated stereotactic radiotherapy for primary optic nerve sheath meningioma.

İrem KoçSezin Yüce SarıGözde YazıcıYasemin KapucuHayyam KıratlıFaruk Zorlu

Published in: Neuro-oncology practice (2023)

Hypofractionated stereotactic radiotherapy is a safe and satisfactory treatment option for primary ONSM without severe toxicity. It may be advisable to commence treatment before an established visual deficit of 20/400 or worse occurs, to make the most of the functional benefit.

Keyphrases

radiation therapy
optic nerve
early stage
brain metastases
radiation induced
squamous cell carcinoma
early onset
optical coherence tomography
combination therapy
replacement therapy
drug induced